Latest News & Updates
Breaking News
25 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Basilea Secures Additional USD 30 Million From BARDA To Advance Phase 3 Antifungal Therapy
Basilea secures an additional $30 million from BARDA after hitting a Phase 3 enrollment milestone for its antifungal therapy fosmanogepix.
Simantini Singh Deo
Nasus Pharma Appoints Industry Veteran Brendan O'Grady To Drive Commercial Growth
Nasus Pharma appoints industry veteran Brendan O'Grady as CEO to drive commercial growth ahead of NS002's pivotal clinical trial.
Simantini Singh Deo
Pluri's Cellav Secures UK Regulatory Registration For Regenativo+ Ahead Of Commercial Launch
Pluri's Cellav secures UK regulatory registration for Regenativo+, clearing its commercial launch in the UK's medical aesthetics market.
Simantini Singh Deo
Starget Pharma Appoints Oncology Experts Oliver Sartor And Michael Hofman To Scientific Advisory Board
Starget Pharma appoints oncology experts Oliver Sartor and Michael Hofman to its Scientific Advisory Board to guide its radioligand therapy pipeline.
Simantini Singh Deo
